Avent, Richard T.,Yang, Philip C.,Lundy, Charles E. Jr.
申请号：
AU2013273760
公开号：
AU2013273760A1
申请日:
2013.12.20
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
#$%^&*AU2013273760A120140116.pdf#####ABSTRACT The present invention discloses the use of potassium 2-(a-hydroxypentyl) benzoate in the manufacture of medicaments for preventing, relieving or treating senile dementia 5 diseases or symptom, and for relieving oxidative stress injury in brain tissue, increasing neural function of choline, protecting neuron and/or raising the content of brain nerve growth factor. The present invention also discloses a pharmaceutical composition comprising potassium 2-(a-hydroxypentyl) benzoate in prophylactically or therapeutically effective dose, optionally, a pharmaceutically acceptable carrier and/or 10 adjuvant. 4962641_1 (GHMatters) P86139AU.1 16/12113
